{"id":8257,"date":"2026-07-13T10:27:57","date_gmt":"2026-07-13T02:27:57","guid":{"rendered":"https:\/\/witology.com.tw\/daily-biohealth\/2026-07-13\/"},"modified":"2026-07-13T10:27:57","modified_gmt":"2026-07-13T02:27:57","slug":"9-92","status":"publish","type":"page","link":"https:\/\/witology.com.tw\/en\/daily-biohealth\/9-92\/","title":{"rendered":"\u751f\u91ab\u5927\u5065\u5eb7\u7522\u696d\u65e5\u5831 2026-07-13\uff5cGSK \u5728\u5169\u6b21\u81e8\u5e8a\u5931\u6557\u5f8c\uff0c\u7d42\u6b62\u8207 Alector \u7e3d"},"content":{"rendered":"\n<style>.wit-daily {\n  --bg:#0f0e0c;--bg2:#16140f;--fg:#e8e3d8;--dim:#8a8276;--mute:#5a5448;\n  --card:#1a1816;--card2:#221f1b;--bdr:#3a342e;--bdr2:#4a423a;\n  --acc:#c4b09a;--acc2:#d4a574;--acc3:#7a6e62;\n  --tw:#e07a6a;--us:#7ab3d4;\n  --up:#8fc78a;--dn:#d97070;--nu:#9a9282;\n  --warn:#d4a574;\n  --line-h:1.85;\n}\n.wit-daily * {margin:0;padding:0;box-sizing:border-box}\n.wit-daily {background:var(--bg)}\n.wit-daily {font-family:\"Noto Sans TC\",sans-serif;background:var(--bg);color:var(--fg);line-height:var(--line-h);-webkit-font-smoothing:antialiased;background-image:radial-gradient(ellipse 80% 40% at 50% 0%,rgba(196,176,154,.06),transparent 70%)}\n.wit-daily .wrap {max-width:860px;margin:0 auto;padding:40px 22px 80px}\n.wit-daily .hdr {text-align:center;padding:64px 0 48px;margin-bottom:48px;border-bottom:1px solid var(--bdr)}\n.wit-daily .hdr-date {font-size:12px;letter-spacing:8px;color:var(--acc);text-transform:uppercase;margin-bottom:14px;font-weight:500}\n.wit-daily .hdr h1 {font-family:\"Noto Serif TC\",serif;font-size:clamp(30px,5vw,46px);font-weight:700;letter-spacing:3px;margin-bottom:12px;background:linear-gradient(135deg,var(--fg) 0%,var(--acc) 100%);-webkit-background-clip:text;-webkit-text-fill-color:transparent;background-clip:text}\n.wit-daily .hdr-sub {font-size:13px;color:var(--dim);letter-spacing:1px}\n.wit-daily .stats {margin-bottom:48px}\n.wit-daily .st {display:flex;align-items:center;gap:12px;margin-bottom:8px}\n.wit-daily .st-bar {height:3px;border-radius:2px;min-width:3px;transition:width .5s;opacity:.85}\n.wit-daily .st-lb {font-size:13px;flex:1;color:var(--fg)}\n.wit-daily .st-ct {font-size:12px;color:var(--dim);min-width:24px;text-align:right;font-variant-numeric:tabular-nums}\n.wit-daily .lbl {font-family:\"Noto Serif TC\",serif;font-size:24px;font-weight:700;color:var(--fg);margin-bottom:28px;padding-bottom:12px;border-bottom:2px solid var(--acc);letter-spacing:1px}\n.wit-daily .c {background:var(--card);border:1px solid var(--bdr);border-radius:4px;margin-bottom:36px;overflow:hidden;box-shadow:0 4px 24px rgba(0,0,0,.35),0 1px 0 rgba(196,176,154,.05) inset;backdrop-filter:blur(16px)}\n.wit-daily .c-hd {display:flex;justify-content:space-between;align-items:center;padding:22px 30px 0}\n.wit-daily .c-cat {font-size:10px;font-weight:700;letter-spacing:3px;text-transform:uppercase;color:var(--cc,var(--acc));border:1px solid var(--cc,var(--acc));padding:3px 12px;border-radius:2px;background:rgba(0,0,0,.2)}\n.wit-daily .c-snt {font-size:13px;font-weight:600;letter-spacing:.5px}\n.wit-daily .s-up {color:var(--up)}\n.wit-daily .s-dn {color:var(--dn)}\n.wit-daily .s-nu {color:var(--nu)}\n.wit-daily .c-t {padding:14px 30px 4px;font-family:\"Noto Serif TC\",serif;font-size:24px;font-weight:700;line-height:1.45;letter-spacing:.5px}\n.wit-daily .c-t a {color:var(--fg);text-decoration:none;transition:color .25s}\n.wit-daily .c-t a:hover {color:var(--acc2)}\n.wit-daily .c-src {padding:0 30px 14px;font-size:12px;color:var(--dim);letter-spacing:.5px}\n.wit-daily .c-hype {display:flex;align-items:center;gap:14px;padding:10px 30px 14px;border-top:1px dashed var(--bdr);border-bottom:1px dashed var(--bdr);background:rgba(196,176,154,.03)}\n.wit-daily .c-hype-lb {font-size:10px;letter-spacing:2px;text-transform:uppercase;color:var(--dim);font-weight:700}\n.wit-daily .c-hype-dots {font-size:14px;color:var(--acc2);letter-spacing:3px;font-family:monospace}\n.wit-daily .c-hype-tx {font-size:12px;color:var(--acc);font-weight:500}\n.wit-daily .c-stocks {padding:14px 30px 18px;display:flex;flex-wrap:wrap;gap:6px}\n.wit-daily .stk {display:inline-flex;align-items:center;gap:4px;font-size:12px;padding:4px 12px;border-radius:2px;font-weight:500}\n.wit-daily .stk b {font-weight:700}\n.wit-daily .stk-tw {background:rgba(224,122,106,.12);color:var(--tw);border:1px solid rgba(224,122,106,.35)}\n.wit-daily .stk-us {background:rgba(122,179,212,.12);color:var(--us);border:1px solid rgba(122,179,212,.35)}\n.wit-daily .stk-other {background:rgba(255,255,255,.04);color:var(--dim);border:1px solid var(--bdr2)}\n.wit-daily .chg {font-size:11px;font-weight:600;padding:1px 6px;border-radius:2px;margin-left:2px}\n.wit-daily .chg-up {background:rgba(226,100,80,.20);color:#ff8f78}\n.wit-daily .chg-down {background:rgba(94,181,141,.20);color:#7ed0a6}\n.wit-daily .chg-flat {background:rgba(255,255,255,.06);color:var(--dim)}\n.wit-daily .c-img {width:100%;height:auto;aspect-ratio:1170\/540;object-fit:cover;border-top:1px solid var(--bdr);border-bottom:1px solid var(--bdr);filter:brightness(.92);display:block}\n.wit-daily .c-analysis {display:grid;grid-template-columns:1fr 1fr;border-top:1px solid var(--bdr)}\n.wit-daily .c-sec {padding:22px 30px;border-bottom:1px solid var(--bdr)}\n.wit-daily .c-sec:nth-child(odd) {border-right:1px solid var(--bdr)}\n.wit-daily .c-wide {grid-column:1\/-1;border-right:none !important}\n.wit-daily .c-sec h4 {font-size:14px;letter-spacing:2px;text-transform:uppercase;color:var(--acc);margin-bottom:12px;font-weight:700}\n.wit-daily .c-sec p {font-size:14px;line-height:var(--line-h);color:var(--fg);opacity:.92}\n.wit-daily .c-counter {background:rgba(212,165,116,.05)}\n.wit-daily .c-counter h4 {color:var(--warn)}\n.wit-daily .c-counter blockquote {border-left:3px solid var(--warn);padding:6px 0 6px 16px;font-size:14px;line-height:var(--line-h);color:var(--fg);opacity:.92;font-style:italic;margin:0}\n.wit-daily .c-watch {background:rgba(196,176,154,.04)}\n.wit-daily .c-watch-grid {display:grid;grid-template-columns:1fr 1fr 1fr;gap:18px;margin-top:6px}\n.wit-daily .c-watch-col {}\n.wit-daily .c-watch-h {font-size:12px;font-weight:700;color:var(--fg);margin-bottom:10px;padding-bottom:6px;border-bottom:1px solid var(--bdr2);display:flex;flex-direction:column;gap:2px}\n.wit-daily .c-watch-h span {font-size:10px;color:var(--dim);letter-spacing:1px;font-weight:400}\n.wit-daily .c-w-short {border-bottom-color:var(--dn)}\n.wit-daily .c-w-mid {border-bottom-color:var(--acc2)}\n.wit-daily .c-w-long {border-bottom-color:var(--up)}\n.wit-daily .c-watch-col ul {list-style:none;padding:0;margin:0}\n.wit-daily .c-watch-col li {font-size:13px;line-height:1.7;color:var(--fg);opacity:.88;padding:6px 0 6px 16px;position:relative}\n.wit-daily .c-watch-col li:before {content:\"\u25b8\";position:absolute;left:0;color:var(--acc);font-size:12px}\n.wit-daily .c-faqs {background:rgba(122,179,212,.04)}\n.wit-daily .c-faqs h4 {color:var(--us)}\n.wit-daily .c-faq-item {border-bottom:1px solid var(--bdr);padding:10px 0}\n.wit-daily .c-faq-item:last-child {border-bottom:none}\n.wit-daily .c-faq-item summary {cursor:pointer;font-size:14px;font-weight:600;color:var(--fg);padding:6px 0;list-style:none;display:flex;align-items:center;gap:10px;transition:color .2s}\n.wit-daily .c-faq-item summary::before {content:\"+\";color:var(--us);font-weight:700;font-size:18px;width:14px;display:inline-block;transition:transform .2s}\n.wit-daily .c-faq-item[open] summary::before {content:\"\u2212\"}\n.wit-daily .c-faq-item summary:hover {color:var(--acc2)}\n.wit-daily .c-faq-item p {font-size:13px;line-height:1.8;color:var(--fg);opacity:.85;padding:8px 0 6px 24px;margin:0}\n.wit-daily .c-ft {padding:16px 30px;border-top:1px solid var(--bdr);text-align:right;background:rgba(0,0,0,.15)}\n.wit-daily .c-ft a {font-size:13px;color:var(--acc);text-decoration:none;font-weight:500;transition:color .25s;letter-spacing:.5px}\n.wit-daily .c-ft a:hover {color:var(--acc2)}\n.wit-daily .briefs {background:var(--card);border:1px solid var(--bdr);border-radius:4px;padding:8px 0;margin-bottom:48px;box-shadow:0 2px 12px rgba(0,0,0,.25)}\n.wit-daily .b-item {display:flex;gap:12px;padding:12px 26px;border-bottom:1px solid var(--bdr);align-items:flex-start}\n.wit-daily .b-item:last-child {border-bottom:none}\n.wit-daily .b-dot {width:7px;height:7px;border-radius:50%;margin-top:9px;flex-shrink:0;box-shadow:0 0 8px currentColor}\n.wit-daily .b-link {color:var(--fg);text-decoration:none;font-size:14px;transition:color .25s;display:block;margin-bottom:2px;line-height:1.6}\n.wit-daily .b-link:hover {color:var(--acc2)}\n.wit-daily .b-meta {font-size:11px;color:var(--dim);letter-spacing:.5px}\n.wit-daily .ftr {text-align:center;padding:36px 0;font-size:11px;color:var(--mute);border-top:1px solid var(--bdr);margin-top:24px;letter-spacing:1px}\n@media(max-width:680px) {.wit-daily .c-analysis {grid-template-columns:1fr}\n.wit-daily .c-sec:nth-child(odd) {border-right:none}\n.wit-daily .c-wide {grid-column:1}\n.wit-daily .c-t {font-size:19px;padding:12px 20px 4px}\n.wit-daily .c-hd, .wit-daily .c-src, .wit-daily .c-stocks, .wit-daily .c-sec, .wit-daily .c-ft, .wit-daily .c-hype {padding-left:20px;padding-right:20px}\n.wit-daily .c-watch-grid {grid-template-columns:1fr;gap:14px}}\n\/* \u5168\u57df(\u975e scoped):\u50c5\u8a72\u7522\u696d\u65e5\u5831\u5b50\u9801\u751f\u6548 *\/\nbody.parent-pageid-7356 .fusion-page-title-bar,\nbody.parent-pageid-7356 .fusion-page-title-row,\nbody.parent-pageid-7356 .fusion-page-title-wrapper {\n  display: none !important;\n  height: 0 !important;\n  padding: 0 !important;\n  margin: 0 !important;\n}\nbody.parent-pageid-7356 #main,\nbody.parent-pageid-7356 #content,\nbody.parent-pageid-7356 .fusion-row,\nbody.parent-pageid-7356 .post-content,\nbody.parent-pageid-7356 article.post {\n  padding-top: 0 !important;\n  margin-top: 0 !important;\n}\n\n\/* scoped(.wit-daily) *\/\n.wit-daily {\n  margin-left: calc((100% - 100vw) \/ 2);\n  margin-right: calc((100% - 100vw) \/ 2);\n  padding-left: calc((100vw - 100%) \/ 2);\n  padding-right: calc((100vw - 100%) \/ 2);\n  padding-top: 40px;\n  padding-bottom: 60px;\n  background: #0f0e0c;\n  color: #e8e3d8;\n  font-family: \"Noto Sans TC\", sans-serif;\n}\n.wit-daily .wrap { padding-left: 22px; padding-right: 22px; padding-top: 0; }\n.wit-daily a { color: inherit; }\n\/* \u5f37\u5236\u8986\u84cb Avada \u4e3b\u984c\u53ef\u80fd\u6ce8\u5165\u7684 blockquote \u767d\u5e95 *\/\n.wit-daily .c-counter blockquote,\n.wit-daily blockquote {\n  background: transparent !important;\n  background-color: transparent !important;\n  color: #e8e3d8 !important;\n  border-left: 3px solid #d4a574 !important;\n  padding: 6px 0 6px 16px !important;\n  font-style: italic !important;\n  margin: 0 !important;\n  box-shadow: none !important;\n}\n.wit-daily .c-counter blockquote::before,\n.wit-daily blockquote::before,\n.wit-daily blockquote::after { content: none !important; }\n<\/style>\n<div class=\"wit-daily\">\n\n<main class=\"wrap\">\n<header class=\"hdr\">\n<div class=\"hdr-date\"><time datetime=\"2026-07-13\">2026 \u5e74 07 \u6708 13 \u65e5<\/time><\/div>\n<h1>\u751f\u91ab\u5927\u5065\u5eb7\u7522\u696d\u65e5\u5831<\/h1>\n<p class=\"hdr-sub\">\u5171\u6536\u9304 7 \u5247\u7522\u696d\u76f8\u95dc\u65b0\u805e \u00b7 2 \u5247\u7cbe\u9078\u6df1\u5ea6\u5206\u6790<\/p>\n<\/header>\n<section aria-labelledby=\"sec-featured\">\n<h2 class=\"lbl\" id=\"sec-featured\">\u7cbe\u9078\u6df1\u5ea6\u5206\u6790<\/h2>\n<article class=\"c\" itemscope=\"\" itemtype=\"https:\/\/schema.org\/NewsArticle\">\n<header class=\"c-hd\">\n<span class=\"c-cat\" style=\"--cc:#4472C4\">\u85e5\u7269<\/span>\n<span class=\"c-snt s-dn\">\u25bc \u504f\u7a7a<\/span>\n<\/header>\n<h3 class=\"c-t\" itemprop=\"headline\"><a href=\"https:\/\/www.fiercebiotech.com\/biotech\/gsk-cuts-losses-700m-upfront-alzheimers-collab-alector-following-two-clinical-failures\" rel=\"noopener nofollow\" target=\"_blank\">GSK \u5728\u5169\u6b21\u81e8\u5e8a\u5931\u6557\u5f8c\uff0c\u7d42\u6b62\u8207 Alector \u7e3d\u984d 7 \u5104\u7f8e\u5143\u7684\u963f\u8332\u6d77\u9ed8\u75c7\u5408\u4f5c\u8a08\u756b<\/a><\/h3>\n<div class=\"c-src\">\u4f86\u6e90\uff1a<span itemprop=\"publisher\">FierceBiotech<\/span> \u00b7 <time datetime=\"2026-07-13\" itemprop=\"datePublished\">2026-07-13<\/time><\/div>\n<div class=\"c-hype\"><span class=\"c-hype-lb\">\u7522\u696d\u91cd\u8981\u6027<\/span><span class=\"c-hype-dots\">\u25cf\u25cf\u25cf\u25cb\u25cb<\/span><span class=\"c-hype-tx\">3\/5 \u00b7 \u503c\u5f97\u95dc\u6ce8<\/span><\/div>\n<div class=\"c-stocks\"><span class=\"stk stk-us\"><b>GSK<\/b> GSK <span class=\"chg chg-up\">\u25b20.59% $52.78<\/span><\/span><span class=\"stk stk-us\"><b>ALEC<\/b> Alector <span class=\"chg chg-down\">\u25bc1.53% $1.61<\/span><\/span><span class=\"stk stk-us\"><b>BIIB<\/b> Biogen <span class=\"chg chg-up\">\u25b20.12% $199.15<\/span><\/span><span class=\"stk stk-other\"><b>4523<\/b> Eisai <span class=\"chg chg-down\">\u25bc0.63% $4269.0<\/span><\/span><span class=\"stk stk-us\"><b>LLY<\/b> Eli Lilly <span class=\"chg chg-down\">\u25bc2.33% $1188.58<\/span><\/span><span class=\"stk stk-other\"><b>ROG<\/b> Roche <span class=\"chg chg-down\">\u25bc1.09% $137.52<\/span><\/span><\/div>\n<section class=\"c-analysis\" itemprop=\"articleBody\">\n<div class=\"c-sec\">\n<h4>\u95dc\u9375\u4e8b\u4ef6<\/h4>\n<p>GSK \u5ba3\u5e03\u7d42\u6b62\u8207\u795e\u7d93\u514d\u75ab\u5b78\u65b0\u5275 Alector \u7684\u963f\u8332\u6d77\u9ed8\u75c7\u5408\u4f5c\u5354\u8b70\uff0c\u6b64\u5408\u4f5c\u65bc 2020 \u5e74\u7c3d\u8a02\u6642\u5148\u671f\u4ed8\u6b3e\u9ad8\u9054 7 \u5104\u7f8e\u5143\uff0c\u7e3d\u6f5b\u5728\u91cc\u7a0b\u7891\u91d1\u984d\u66f4\u903e 15 \u5104\u7f8e\u5143\u3002\u5169\u6b3e\u5019\u9078\u85e5\u7269\uff08AL002 \u91dd\u5c0d TREM2 \u8def\u5f91\u3001AL003 \u91dd\u5c0d CD33 \u8def\u5f91\uff09\u5728\u81e8\u5e8a\u8a66\u9a57\u4e2d\u76f8\u7e7c\u5931\u6557\uff0cGSK \u6c7a\u5b9a\u8a8d\u8ce0\u51fa\u5834\u3002\u6b64\u8209\u51f8\u986f\u4ee5\u5148\u5929\u514d\u75ab\uff0f\u795e\u7d93\u708e\u75c7\u70ba\u9776\u9ede\u7684\u963f\u8332\u6d77\u9ed8\u75c7\u7b56\u7565\u9762\u81e8\u56b4\u5cfb\u6311\u6230\uff0c\u4e5f\u53cd\u6620\u5927\u85e5\u5ee0\u5728 AD \u7ba1\u7dda\u6574\u7406\u4e0a\u6108\u8da8\u4fdd\u5b88\u3002<\/p>\n<\/div>\n<div class=\"c-sec\">\n<h4>\u95dc\u9375\u6578\u64da<\/h4>\n<p>GSK \u5c0d Alector \u7684\u5148\u671f\u4ed8\u6b3e\u70ba 7 \u5104\u7f8e\u5143\uff082020 \u5e74\uff09\uff0c\u5408\u4f5c\u7e3d\u6f5b\u5728\u50f9\u503c\u903e 15 \u5104\u7f8e\u5143\uff1bAlector \u5e02\u503c\u5728\u6d88\u606f\u524d\u5f8c\u5927\u5e45\u7e2e\u6c34\uff0c\u80a1\u50f9\u6b77\u53f2\u9ad8\u9ede\u66fe\u903e 50 \u7f8e\u5143\uff1b\u5168\u7403\u963f\u8332\u6d77\u9ed8\u75c7\u85e5\u7269\u5e02\u5834\u9810\u4f30 2030 \u5e74\u9054 200 \u5104\u7f8e\u5143\u4ee5\u4e0a\uff1b\u76ee\u524d\u5df2\u7372 FDA \u6838\u51c6\u7684 AD \u6297\u6fb1\u7c89\u86cb\u767d\u6297\u9ad4\uff08lecanemab\u3001donanemab\uff091 \u5e74\u7642\u7a0b\u8cbb\u7528\u7d04 2.6\u20133.2 \u842c\u7f8e\u5143\uff1bTREM2 \/ CD33 \u9776\u9ede\u7684\u795e\u7d93\u708e\u75c7\u8def\u5f91\u76ee\u524d\u5c1a\u7121\u4efb\u4f55\u85e5\u7269\u6210\u529f\u5b8c\u6210 Phase III\u3002<\/p>\n<\/div>\n<div class=\"c-sec c-wide\">\n<h4>\u5e02\u5834\u91cd\u8981\u6027<\/h4>\n<p>GSK \u7d42\u6b62\u8207 Alector \u7684\u5408\u4f5c\uff0c\u662f\u963f\u8332\u6d77\u9ed8\u75c7\u300c\u795e\u7d93\u514d\u75ab\u708e\u75c7\u8def\u5f91\u300d\u6574\u689d\u6280\u8853\u8def\u7dda\u906d\u9047\u91cd\u5927\u632b\u6557\u7684\u5177\u9ad4\u7e2e\u5f71\uff0c\u986f\u793a\u5e02\u5834\u5c0d\u9019\u4e00\u8def\u5f91\u7684\u4fe1\u5fc3\u6b63\u5728\u52d5\u6416\u3002\u76f8\u5c0d\u65bc\u5df2\u7372\u6279\u7684\u6297\u6fb1\u7c89\u86cb\u767d\u6297\u9ad4\u7642\u6cd5\uff08lecanemab\u3001donanemab\uff09\uff0cTREM2\uff0fCD33 \u7b49\u5148\u5929\u514d\u75ab\u9776\u9ede\u7684\u81e8\u5e8a\u8f49\u5316\u7387\u6975\u4f4e\uff0c\u5927\u85e5\u5ee0\u958b\u59cb\u91cd\u65b0\u8a55\u4f30\u5728\u6b64\u8def\u5f91\u4e0a\u7684\u8cc7\u672c\u914d\u7f6e\u3002\u5c0d\u53f0\u7063\u751f\u91ab\u7522\u696d\u800c\u8a00\uff0c\u90e8\u5206\u4ee5\u795e\u7d93\u708e\u75c7\u70ba\u5207\u5165\u9ede\u7684\u5c0f\u578b\u65b0\u85e5\u516c\u53f8\u9700\u8b66\u60d5\u6388\u6b0a\u8ac7\u5224\u96e3\u5ea6\u4e0a\u5347\uff1b\u4f46\u53cd\u9762\u4f86\u770b\uff0c\u795e\u7d93\u514d\u75ab\u8def\u5f91\u7684\u5931\u6557\u4e5f\u70ba\u805a\u7126 tau \u86cb\u767d\u3001\u7a81\u89f8\u4fdd\u8b77\u7b49\u5dee\u7570\u5316\u9776\u9ede\u7684\u516c\u53f8\u5275\u9020\u76f8\u5c0d\u512a\u52e2\u3002\u6b64\u4e8b\u4ef6\u540c\u6642\u63d0\u9192 CDMO \u53ca CRO \u696d\u8005\uff08\u5982\u85e5\u83ef\u85e5\u3001\u6631\u5c55\u65b0\u85e5\u76f8\u95dc\u5408\u4f5c\u65b9\uff09\uff0c\u963f\u8332\u6d77\u9ed8\u75c7\u81e8\u5e8a\u59d4\u8a17\u9700\u6c42\u77ed\u671f\u5167\u53ef\u80fd\u56e0\u7ba1\u7dda\u7e2e\u6e1b\u800c\u964d\u6eab\u3002<\/p>\n<\/div>\n<div class=\"c-sec c-wide c-counter\">\n<h4>\u26a0 \u53cd\u9762\u89c0\u9ede<\/h4>\n<blockquote>\u90e8\u5206\u5206\u6790\u5e2b\u8a8d\u70ba TREM2 \u8def\u5f91\u4e26\u672a\u5b8c\u5168\u6b7b\u4ea1\u2014\u2014AL002 \u7684\u5931\u6557\u53ef\u80fd\u6e90\u65bc\u5291\u91cf\u8a2d\u8a08\u6216\u60a3\u8005\u65cf\u7fa4\u7be9\u9078\u4e0d\u7576\uff0c\u800c\u975e\u9776\u9ede\u672c\u8eab\u7121\u6548\uff1b\u6cc1\u4e14 Alzheimer&#8217;s \u5e02\u5834\u9f90\u5927\uff0c\u5176\u4ed6\u516c\u53f8\uff08\u5982 Vigil Neuroscience\uff09\u4ecd\u5728\u63a8\u9032 TREM2 \u6291\u5236\u5291\uff0cGSK \u7684\u9000\u51fa\u6216\u8a31\u66f4\u591a\u53cd\u6620\u5176\u7ba1\u7dda\u512a\u5148\u9806\u5e8f\u8abf\u6574\uff0c\u800c\u975e\u5c0d\u6574\u500b\u8def\u5f91\u7684\u5426\u5b9a\u3002<\/blockquote>\n<\/div>\n<div class=\"c-sec c-wide c-watch\">\n<h4>\ud83d\udccd \u63a5\u4e0b\u4f86\u89c0\u5bdf<\/h4>\n<div class=\"c-watch-grid\">\n<div class=\"c-watch-col\"><div class=\"c-watch-h c-w-short\">\ud83d\udd25 \u77ed\u671f\u50ac\u5316\u5291<span>1-3 \u500b\u6708<\/span><\/div><ul><li>Alector \u662f\u5426\u80fd\u5728 6 \u500b\u6708\u5167\u53e6\u8993\u65b0\u5408\u4f5c\u5925\u4f34\u6216\u53d6\u5f97\u975e\u7a00\u91cb\u6027\u878d\u8cc7\u4ee5\u5ef6\u7e8c\u7ba1\u7dda<\/li><li>GSK \u662f\u5426\u516c\u958b\u8aaa\u660e\u672a\u4f86 AD \u7ba1\u7dda\u7b56\u7565\u8abf\u6574\u65b9\u5411\uff08\u5982\u8f49\u5411 tau \u6216 synaptic \u8def\u5f91\uff09<\/li><\/ul><\/div>\n<div class=\"c-watch-col\"><div class=\"c-watch-h c-w-mid\">\ud83d\udc41 \u4e2d\u671f\u89c0\u5bdf<span>3-12 \u500b\u6708<\/span><\/div><ul><li>\u5176\u4ed6\u4ee5 TREM2\uff0fCD33 \u70ba\u9776\u9ede\u7684\u516c\u53f8\uff08\u5982 Vigil Neuroscience\uff09\u4e2d\u671f\u81e8\u5e8a\u6578\u64da\u662f\u5426\u80fd\u70ba\u6b64\u8def\u5f91\u5e73\u53cd<\/li><li>lecanemab\uff08Biogen\/Eisai\uff09\u8207 donanemab\uff08Lilly\uff09\u7684\u771f\u5be6\u4e16\u754c\u6578\u64da\u662f\u5426\u6301\u7e8c\u652f\u6490\u6297\u6fb1\u7c89\u86cb\u767d\u8def\u5f91\u7684\u4e3b\u6d41\u5730\u4f4d<\/li><\/ul><\/div>\n<div class=\"c-watch-col\"><div class=\"c-watch-h c-w-long\">\ud83c\udfaf \u9577\u671f\u8b8a\u6578<span>1 \u5e74\u4ee5\u4e0a<\/span><\/div><ul><li>\u795e\u7d93\u708e\u75c7\u8def\u5f91\u80fd\u5426\u5728\u4e0b\u4e00\u4ee3\u751f\u7269\u6a19\u8a18\u7be9\u9078\u6280\u8853\uff08\u5982 PET \u6216\u8840\u6db2 biomarker\uff09\u8f14\u52a9\u4e0b\u91cd\u65b0\u627e\u5230\u6709\u6548\u60a3\u8005\u65cf\u7fa4<\/li><li>AD \u6cbb\u7642\u662f\u5426\u9010\u6b65\u8d70\u5411\u300c\u7d44\u5408\u7642\u6cd5\u300d\uff08\u6297\u6fb1\u7c89\u86cb\u767d + \u6297\u708e\u75c7\uff09\uff0c\u958b\u555f\u65b0\u4e00\u8f2a\u5408\u4f5c\u6388\u6b0a\u683c\u5c40<\/li><\/ul><\/div>\n<\/div>\n<\/div>\n<div class=\"c-sec c-wide c-faqs\">\n<h4>\u2753 \u5e38\u898b\u554f\u984c<\/h4>\n<details class=\"c-faq-item\"><summary>GSK \u6295\u5165\u7684 7 \u5104\u7f8e\u5143\u5c31\u9019\u6a23\u6253\u6c34\u6f02\u4e86\u55ce\uff1f<\/summary><p>\u57fa\u672c\u4e0a\u662f\u7684\u3002\u5148\u671f\u4ed8\u6b3e\u5c6c\u65bc\u4e0d\u53ef\u9000\u6b3e\u6027\u8cea\uff0c\u5169\u6b3e\u5019\u9078\u85e5\u7269\u81e8\u5e8a\u5931\u6557\u5f8c GSK \u7121\u6cd5\u56de\u6536\u9019\u7b46\u6b3e\u9805\uff1b\u4f46\u7d42\u6b62\u5408\u4f5c\u53ef\u907f\u514d\u672a\u4f86\u7e7c\u7e8c\u71d2\u9322\u5728\u7121\u6548\u7ba1\u7dda\u4e0a\uff0c\u5c0d GSK \u800c\u8a00\u662f\u300c\u6b62\u8840\u300d\u800c\u975e\u300c\u7372\u5229\u300d\u7684\u6c7a\u7b56\u3002<\/p><\/details><details class=\"c-faq-item\"><summary>\u9019\u6b21\u5931\u6557\u4ee3\u8868\u963f\u8332\u6d77\u9ed8\u75c7\u7684\u795e\u7d93\u708e\u75c7\u7642\u6cd5\u6574\u689d\u8def\u90fd\u8d70\u4e0d\u901a\u55ce\uff1f<\/summary><p>\u76ee\u524d\u4e0d\u80fd\u5b8c\u5168\u4e0b\u9019\u500b\u7d50\u8ad6\uff0c\u4f46 TREM2 \u8207 CD33 \u5169\u500b\u9776\u9ede\u76f8\u7e7c\u5728\u81e8\u5e8a\u5931\u6557\uff0c\u78ba\u5be6\u8b93\u5e02\u5834\u5c0d\u5148\u5929\u514d\u75ab\u8def\u5f91\u7684\u4fe1\u5fc3\u5927\u5e45\u4e0b\u6ed1\uff1b\u76ee\u524d\u79d1\u5b78\u754c\u5171\u8b58\u4ecd\u504f\u5411\u6297\u6fb1\u7c89\u86cb\u767d\u8def\u5f91\uff08\u5982 lecanemab\uff09\u662f\u6700\u63a5\u8fd1\u81e8\u5e8a\u6709\u6548\u7684\u7b56\u7565\uff0c\u795e\u7d93\u708e\u75c7\u8def\u5f91\u9700\u8981\u66f4\u7cbe\u6e96\u7684\u60a3\u8005\u7be9\u9078\u8207\u751f\u7269\u6a19\u8a18\u624d\u53ef\u80fd\u7ffb\u76e4\u3002<\/p><\/details><details class=\"c-faq-item\"><summary>Alector \u63a5\u4e0b\u4f86\u600e\u9ebc\u8fa6\uff0c\u9019\u5bb6\u516c\u53f8\u9084\u6709\u6551\u55ce\uff1f<\/summary><p>Alector \u76ee\u524d\u4ecd\u6709\u5176\u4ed6\u7ba1\u7dda\uff08\u5982\u91dd\u5c0d FTD \u7684 progranulin \u8def\u5f91 AL101\uff09\uff0c\u4f46\u5931\u53bb GSK \u7684\u8cc7\u91d1\u652f\u6301\u5f8c\u73fe\u91d1\u8dd1\u9053\u58d3\u529b\u5927\u589e\uff0c\u77ed\u671f\u5167\u9700\u8981\u5c0b\u627e\u65b0\u7684\u6388\u6b0a\u5925\u4f34\u6216\u9032\u884c\u878d\u8cc7\uff0c\u80a1\u50f9\u8207\u516c\u53f8\u5b58\u7e8c\u98a8\u96aa\u5747\u986f\u8457\u4e0a\u5347\u3002<\/p><\/details>\n<\/div>\n<\/section>\n<footer class=\"c-ft\"><a href=\"https:\/\/www.fiercebiotech.com\/biotech\/gsk-cuts-losses-700m-upfront-alzheimers-collab-alector-following-two-clinical-failures\" rel=\"noopener nofollow\" target=\"_blank\">\u95b1\u8b80\u539f\u6587 \u2192<\/a><\/footer>\n<\/article>\n<article class=\"c\" itemscope=\"\" itemtype=\"https:\/\/schema.org\/NewsArticle\">\n<header class=\"c-hd\">\n<span class=\"c-cat\" style=\"--cc:#70AD47\">\u65b0\u8208\u7642\u6cd5<\/span>\n<span class=\"c-snt s-up\">\u25b2 \u504f\u591a<\/span>\n<\/header>\n<h3 class=\"c-t\" itemprop=\"headline\"><a href=\"https:\/\/www.fiercebiotech.com\/biotech\/fates-shelf-car-t-cell-therapy-shows-early-promise-treatment-resistant-autoimmune-disease\" rel=\"noopener nofollow\" target=\"_blank\">Fate Therapeutics \u7684\u73fe\u6210\u578b CAR-T \u7d30\u80de\u7642\u6cd5\u5728\u96e3\u6cbb\u6027\u81ea\u9ad4\u514d\u75ab\u75be\u75c5\u4e2d\u5c55\u73fe\u65e9\u671f\u7642\u6548<\/a><\/h3>\n<div class=\"c-src\">\u4f86\u6e90\uff1a<span itemprop=\"publisher\">FierceBiotech<\/span> \u00b7 <time datetime=\"2026-07-13\" itemprop=\"datePublished\">2026-07-13<\/time><\/div>\n<div class=\"c-hype\"><span class=\"c-hype-lb\">\u7522\u696d\u91cd\u8981\u6027<\/span><span class=\"c-hype-dots\">\u25cf\u25cf\u25cf\u25cf\u25cb<\/span><span class=\"c-hype-tx\">4\/5 \u00b7 \u91cd\u5927\u8a0a\u865f<\/span><\/div>\n<div class=\"c-stocks\"><span class=\"stk stk-us\"><b>FATE<\/b> Fate Therapeutics <span class=\"chg chg-down\">\u25bc0.32% $3.1<\/span><\/span><span class=\"stk stk-us\"><b>BMY<\/b> Bristol Myers Squibb <span class=\"chg chg-down\">\u25bc0.62% $57.58<\/span><\/span><span class=\"stk stk-us\"><b>KYTX<\/b> Kyverna Therapeutics <span class=\"chg chg-down\">\u25bc13.51% $8.48<\/span><\/span><span class=\"stk stk-us\"><b>CRXT<\/b> Cartesian Therapeutics <span class=\"chg chg-flat\">\u2014<\/span><\/span><span class=\"stk stk-us\"><b>NVS<\/b> Novartis <span class=\"chg chg-down\">\u25bc0.37% $154.05<\/span><\/span><span class=\"stk stk-us\"><b>JNJ<\/b> Johnson &amp; Johnson <span class=\"chg chg-down\">\u25bc0.82% $256.98<\/span><\/span><span class=\"stk stk-tw\"><b>6712<\/b> \u9577\u8056\u570b\u969b\u751f\u6280 <span class=\"chg chg-flat\">\u2014<\/span><\/span><\/div>\n<section class=\"c-analysis\" itemprop=\"articleBody\">\n<div class=\"c-sec\">\n<h4>\u95dc\u9375\u4e8b\u4ef6<\/h4>\n<p>Fate Therapeutics \u516c\u5e03\u5176\u7570\u9ad4\uff08\u73fe\u6210\u578b\uff09CAR-T \u7d30\u80de\u7642\u6cd5 FT819 \u5728\u6cbb\u7642\u96e3\u6cbb\u6027\u81ea\u9ad4\u514d\u75ab\u75be\u75c5\uff08\u5982\u7cfb\u7d71\u6027\u7d05\u6591\u72fc\u7621\u3001\u91cd\u75c7\u808c\u7121\u529b\u7b49\uff09\u7684\u65e9\u671f\u81e8\u5e8a\u6578\u64da\uff0c\u986f\u793a\u51fa\u521d\u6b65\u7642\u6548\u8a0a\u865f\u4e14\u5b89\u5168\u6027\u53ef\u63a5\u53d7\u3002\u76f8\u8f03\u65bc\u81ea\u9ad4 CAR-T\uff0cFate \u7684\u7570\u9ad4\u5e73\u53f0\u4f7f\u7528\u5065\u5eb7\u6350\u8d08\u8005\u7684 iPSC \u4f86\u6e90 T \u7d30\u80de\uff0c\u53ef\u505a\u5230\u300c\u73fe\u6210\u5373\u7528\u300d\uff0c\u89e3\u6c7a\u81ea\u9ad4\u7d30\u80de\u88fd\u9020\u6642\u9593\u904e\u9577\u7684\u75db\u9ede\u3002\u9019\u662f CAR-T \u7642\u6cd5\u5f9e\u8840\u6db2\u816b\u7624\u8de8\u5165\u81ea\u9ad4\u514d\u75ab\u75be\u75c5\u7684\u91cd\u8981\u81e8\u5e8a\u9032\u5c55\u4e4b\u4e00\u3002<\/p>\n<\/div>\n<div class=\"c-sec\">\n<h4>\u95dc\u9375\u6578\u64da<\/h4>\n<p>\u5168\u7403\u81ea\u9ad4\u514d\u75ab\u75be\u75c5 CAR-T \u7642\u6cd5\u5e02\u5834\u9810\u4f30 2030 \u5e74\u53ef\u9054 50 \u5104\u7f8e\u5143\u4ee5\u4e0a\uff1b\u81ea\u9ad4 CAR-T\uff08\u5982 Kymriah\uff09\u6bcf\u7642\u7a0b\u8cbb\u7528 37\u201347 \u842c\u7f8e\u5143\uff0c\u7570\u9ad4 CAR-T \u76ee\u6a19\u5c07\u6210\u672c\u58d3\u4f4e\u81f3\u81ea\u9ad4\u7684 1\/3 \u81f3 1\/5\uff1bFate Therapeutics \u5e02\u503c\u7d04 3\u20135 \u5104\u7f8e\u5143\uff082024\u20132025 \u5e74\u5927\u5e45\u7e2e\u6c34\u5f8c\uff09\uff1bBMS \u65d7\u4e0b Breyanzi \u5df2\u5728\u63a2\u7d22\u81ea\u9ad4\u514d\u75ab\u9069\u61c9\u75c7\uff1b\u96e3\u6cbb\u6027 SLE \u60a3\u8005\u5168\u7403\u4f30\u8a08\u903e 150 \u842c\u4eba\uff0c\u73fe\u6709\u751f\u7269\u88fd\u5291\uff08belimumab\u3001anifrolumab\uff09\u61c9\u7b54\u7387\u4e0d\u8db3 50%\u3002<\/p>\n<\/div>\n<div class=\"c-sec c-wide\">\n<h4>\u5e02\u5834\u91cd\u8981\u6027<\/h4>\n<p>\u7570\u9ad4\u73fe\u6210\u578b CAR-T \u9032\u5165\u81ea\u9ad4\u514d\u75ab\u75be\u75c5\u9818\u57df\uff0c\u662f\u7d30\u80de\u6cbb\u7642\u7e7c\u8840\u6db2\u816b\u7624\u5f8c\u6700\u5177\u5546\u696d\u6f5b\u529b\u7684\u64f4\u5f35\u65b9\u5411\uff0c\u4e00\u65e6\u5b89\u5168\u6027\u8207\u6301\u4e45\u7642\u6548\u5728\u8f03\u5927\u6a23\u672c\u4e2d\u5f97\u5230\u9a57\u8b49\uff0c\u5c07\u5c0d\u73fe\u6709\u751f\u7269\u88fd\u5291\u5e02\u5834\uff08JAK \u6291\u5236\u5291\u3001\u6297\u9ad4\u7642\u6cd5\uff09\u5f62\u6210\u985b\u8986\u6027\u7af6\u722d\u3002\u81ea\u9ad4\u514d\u75ab\u75be\u75c5\u60a3\u8005\u6578\u91cf\u9060\u8d85\u8840\u6db2\u764c\u75c7\uff0c\u82e5\u7570\u9ad4 CAR-T \u80fd\u4ee5\u66f4\u4f4e\u6210\u672c\u5be6\u73fe\u300c\u4e00\u6b21\u6cbb\u7642\u3001\u9577\u6548\u7de9\u89e3\u300d\uff0c\u5e02\u5834\u898f\u6a21\u5c07\u6578\u500d\u65bc\u76ee\u524d\u7684\u8840\u6db2\u816b\u7624 CAR-T \u5e02\u5834\u3002\u53f0\u7063\u7d30\u80de\u6cbb\u7642\u696d\u8005\uff08\u5982\u9577\u8056\u570b\u969b\uff09\u76ee\u524d\u805a\u7126\u81ea\u9ad4 NK\uff0fT \u7d30\u80de\u5e73\u53f0\uff0c\u61c9\u5bc6\u5207\u95dc\u6ce8\u7570\u9ad4 iPSC \u8def\u7dda\u7684\u6280\u8853\u6f14\u9032\uff0c\u8a55\u4f30\u662f\u5426\u9700\u8981\u8abf\u6574\u5e73\u53f0\u7b56\u7565\u3002\u5c0d\u6574\u500b\u7522\u696d\u800c\u8a00\uff0cFate \u7684\u65e9\u671f\u6578\u64da\u82e5\u80fd\u5728\u5f8c\u7e8c\u8a66\u9a57\u7dad\u6301\uff0c\u5c07\u5f15\u767c\u5927\u85e5\u5ee0\u65b0\u4e00\u8f2a\u6388\u6b0a\u6216\u4f75\u8cfc\u71b1\u6f6e\u3002<\/p>\n<\/div>\n<div class=\"c-sec c-wide c-counter\">\n<h4>\u26a0 \u53cd\u9762\u89c0\u9ede<\/h4>\n<blockquote>\u300c\u65e9\u671f\u7642\u6548\u8a0a\u865f\u300d\u5728 CAR-T \u81ea\u9ad4\u514d\u75ab\u9818\u57df\u5df2\u5c62\u898b\u4e0d\u9bae\uff0c\u4f46\u5f9e Phase I \u5230 Phase III \u7684\u6210\u529f\u7387\u6975\u4f4e\uff1b\u7570\u9ad4 CAR-T \u9762\u81e8\u5bbf\u4e3b\u514d\u75ab\u6392\u65a5\uff08GvHD \u8207 HvG\uff09\u7684\u6839\u672c\u6027\u6280\u8853\u6311\u6230\uff0cFate \u7684 iPSC \u5e73\u53f0\u904e\u53bb\u5728\u8840\u6db2\u816b\u7624\u7684\u591a\u500b\u8a66\u9a57\u4e2d\u5747\u672a\u9054\u9810\u671f\uff0c\u6295\u8cc7\u4eba\u5c0d\u300c\u65e9\u671f\u627f\u8afe\u300d\u61c9\u4fdd\u6301\u9ad8\u5ea6\u5be9\u614e\u3002<\/blockquote>\n<\/div>\n<div class=\"c-sec c-wide c-watch\">\n<h4>\ud83d\udccd \u63a5\u4e0b\u4f86\u89c0\u5bdf<\/h4>\n<div class=\"c-watch-grid\">\n<div class=\"c-watch-col\"><div class=\"c-watch-h c-w-short\">\ud83d\udd25 \u77ed\u671f\u50ac\u5316\u5291<span>1-3 \u500b\u6708<\/span><\/div><ul><li>Fate \u662f\u5426\u5728\u8fd1\u671f\u91ab\u5b78\u5927\u6703\uff08\u5982 ACR \u6216 ASH\uff09\u516c\u5e03\u66f4\u591a\u60a3\u8005\u6578\u64da\u53ca\u5b8c\u6574\u7de9\u89e3\u7387<\/li><li>\u516c\u53f8\u73fe\u91d1\u8dd1\u9053\u80fd\u5426\u652f\u6490\u81f3\u4e0b\u4e00\u500b\u95dc\u9375\u81e8\u5e8a\u91cc\u7a0b\u7891\uff0c\u662f\u5426\u9700\u8981\u7dca\u6025\u878d\u8cc7\u6216\u5c0b\u627e\u5408\u4f5c\u5925\u4f34<\/li><\/ul><\/div>\n<div class=\"c-watch-col\"><div class=\"c-watch-h c-w-mid\">\ud83d\udc41 \u4e2d\u671f\u89c0\u5bdf<span>3-12 \u500b\u6708<\/span><\/div><ul><li>FT819 \u5728\u81ea\u9ad4\u514d\u75ab\u9069\u61c9\u75c7\u7684 Phase II \u8a66\u9a57\u8a2d\u8a08\u662f\u5426\u7372 FDA \u8a8d\u53ef\uff0c\u60a3\u8005\u5165\u7d44\u901f\u5ea6\u5982\u4f55<\/li><li>\u7af6\u722d\u5c0d\u624b Kyverna\uff08\u81ea\u9ad4 CAR-T\uff09\u8207 Cartesian \u7684\u540c\u985e\u578b\u6578\u64da\u662f\u5426\u5728 12 \u500b\u6708\u5167\u5f62\u6210\u5c0d\u6bd4\u58d3\u529b<\/li><\/ul><\/div>\n<div class=\"c-watch-col\"><div class=\"c-watch-h c-w-long\">\ud83c\udfaf \u9577\u671f\u8b8a\u6578<span>1 \u5e74\u4ee5\u4e0a<\/span><\/div><ul><li>\u7570\u9ad4 iPSC \u4f86\u6e90 CAR-T \u662f\u5426\u80fd\u5728\u5927\u898f\u6a21\u751f\u7522\u4e2d\u7dad\u6301\u7d30\u80de\u54c1\u8cea\u4e00\u81f4\u6027\uff0c\u6210\u672c\u662f\u5426\u771f\u80fd\u4f4e\u65bc\u81ea\u9ad4\u7642\u6cd5<\/li><li>\u76e3\u7ba1\u6a5f\u69cb\uff08FDA\u3001EMA\uff09\u5982\u4f55\u5efa\u7acb\u7570\u9ad4 CAR-T \u7528\u65bc\u81ea\u9ad4\u514d\u75ab\u75be\u75c5\u7684\u5be9\u67e5\u6846\u67b6\u8207\u9577\u671f\u5b89\u5168\u8ffd\u8e64\u8981\u6c42<\/li><\/ul><\/div>\n<\/div>\n<\/div>\n<div class=\"c-sec c-wide c-faqs\">\n<h4>\u2753 \u5e38\u898b\u554f\u984c<\/h4>\n<details class=\"c-faq-item\"><summary>\u300c\u73fe\u6210\u578b\u300dCAR-T \u548c\u4e00\u822c CAR-T \u6709\u4ec0\u9ebc\u4e0d\u540c\uff0c\u70ba\u4ec0\u9ebc\u9019\u5f88\u91cd\u8981\uff1f<\/summary><p>\u4e00\u822c\uff08\u81ea\u9ad4\uff09CAR-T \u9700\u8981\u62bd\u53d6\u75c5\u4eba\u81ea\u5df1\u7684 T \u7d30\u80de\u3001\u6539\u9020\u5f8c\u518d\u56de\u8f38\uff0c\u6574\u500b\u904e\u7a0b\u9700 4\u20136 \u9031\u4e14\u8cbb\u7528\u6975\u9ad8\uff1b\u300c\u73fe\u6210\u578b\u300d\uff08\u7570\u9ad4\uff09CAR-T \u4f7f\u7528\u5065\u5eb7\u6350\u8d08\u8005\u7d30\u80de\u9810\u5148\u5927\u91cf\u88fd\u9020\uff0c\u75c5\u4eba\u9700\u8981\u6642\u53ef\u7acb\u5373\u4f7f\u7528\uff0c\u7406\u8ad6\u4e0a\u6210\u672c\u66f4\u4f4e\u3001\u7b49\u5f85\u6642\u9593\u66f4\u77ed\uff0c\u5c0d\u91cd\u75c7\u60a3\u8005\u5c24\u5176\u95dc\u9375\u3002<\/p><\/details><details class=\"c-faq-item\"><summary>CAR-T \u7642\u6cd5\u7528\u65bc\u81ea\u9ad4\u514d\u75ab\u75be\u75c5\u548c\u7528\u65bc\u764c\u75c7\u6cbb\u7642\u6709\u4f55\u4e0d\u540c\uff1f<\/summary><p>\u5728\u764c\u75c7\u4e2d\uff0cCAR-T \u7684\u76ee\u6a19\u662f\u6d88\u6ec5\u816b\u7624\u7d30\u80de\uff1b\u5728\u81ea\u9ad4\u514d\u75ab\u75be\u75c5\u4e2d\uff0c\u76ee\u6a19\u662f\u6e05\u9664\u300c\u932f\u8aa4\u653b\u64ca\u81ea\u8eab\u7d44\u7e54\u300d\u7684\u7570\u5e38 B \u7d30\u80de\uff0c\u8b93\u514d\u75ab\u7cfb\u7d71\u91cd\u65b0\u5efa\u7acb\u6b63\u78ba\u7684\u8010\u53d7\u6a5f\u5236\uff0c\u56e0\u6b64\u6cbb\u7642\u908f\u8f2f\u662f\u300c\u514d\u75ab\u91cd\u7f6e\u300d\u800c\u975e\u300c\u6bba\u764c\u300d\uff0c\u5c0d\u7d30\u80de\u6bd2\u6027\u7684\u8981\u6c42\u4e5f\u4e0d\u540c\u3002<\/p><\/details><details class=\"c-faq-item\"><summary>\u9019\u500b\u7642\u6cd5\u8ddd\u96e2\u771f\u6b63\u4e0a\u5e02\u9084\u6709\u591a\u9060\uff1f<\/summary><p>\u76ee\u524d\u50c5\u70ba\u65e9\u671f\u81e8\u5e8a\uff08Phase I\uff09\u7684\u521d\u6b65\u8a0a\u865f\uff0c\u8ddd\u96e2\u53d6\u5f97 FDA \u6279\u51c6\u901a\u5e38\u9084\u9700\u8981 5\u20138 \u5e74\u7684 Phase II\uff0fIII \u8a66\u9a57\uff1b\u52a0\u4e0a\u7570\u9ad4 CAR-T \u5728\u81ea\u9ad4\u514d\u75ab\u75be\u75c5\u7684\u76e3\u7ba1\u8def\u5f91\u5c1a\u672a\u5b8c\u5168\u78ba\u7acb\uff0c\u5546\u696d\u5316\u6642\u7a0b\u5b58\u5728\u76f8\u7576\u4e0d\u78ba\u5b9a\u6027\u3002<\/p><\/details>\n<\/div>\n<\/section>\n<footer class=\"c-ft\"><a href=\"https:\/\/www.fiercebiotech.com\/biotech\/fates-shelf-car-t-cell-therapy-shows-early-promise-treatment-resistant-autoimmune-disease\" rel=\"noopener nofollow\" target=\"_blank\">\u95b1\u8b80\u539f\u6587 \u2192<\/a><\/footer>\n<\/article>\n<\/section>\n<section aria-labelledby=\"sec-briefs\">\n<h2 class=\"lbl\" id=\"sec-briefs\">\u4eca\u65e5\u5feb\u8a0a<\/h2>\n<ul class=\"briefs\" style=\"list-style:none\">\n<li class=\"b-item\">\n<span class=\"b-dot\" style=\"background:#4472C4\"><\/span>\n<div><a class=\"b-link\" href=\"https:\/\/www.fiercebiotech.com\/biotech\/gsk-sees-phase-3-win-hansoh-partnered-adc-china-justifying-hype\" rel=\"noopener nofollow\" target=\"_blank\">GSK sees phase 3 win for Hansoh-partnered ADC in China as validating its &#8216;priority asset&#8217;<\/a>\n<span class=\"b-meta\">\u85e5\u7269 \u00b7 FierceBiotech<\/span><\/div>\n<\/li>\n<li class=\"b-item\">\n<span class=\"b-dot\" style=\"background:#5B9BD5\"><\/span>\n<div><a class=\"b-link\" href=\"https:\/\/www.fiercebiotech.com\/medtech\/ihealthscreen-garners-fda-nod-ai-backed-dx-spot-mild-diabetic-retinopathy\" rel=\"noopener nofollow\" target=\"_blank\">IHealthScreen nabs FDA nod for AI-backed dx to spot mild diabetic retinopathy<\/a>\n<span class=\"b-meta\">\u6578\u4f4d\u5065\u5eb7\u91ab\u7642\u79d1\u6280 \u00b7 FierceBiotech<\/span><\/div>\n<\/li>\n<li class=\"b-item\">\n<span class=\"b-dot\" style=\"background:#4472C4\"><\/span>\n<div><a class=\"b-link\" href=\"https:\/\/www.fiercebiotech.com\/biotech\/unseen-impact-how-one-big-beautiful-bill-act-could-hamper-drug-development\" rel=\"noopener nofollow\" target=\"_blank\">Why biotech revenue projections &#8216;won&#8217;t look as sunny&#8217; once Trump tax bill hits Medicaid enrollment<\/a>\n<span class=\"b-meta\">\u85e5\u7269 \u00b7 FierceBiotech<\/span><\/div>\n<\/li>\n<\/ul>\n<\/section>\n<section aria-labelledby=\"sec-stats\" class=\"stats\" style=\"margin-top:48px\">\n<h2 class=\"lbl\" id=\"sec-stats\" style=\"font-size:16px;border-bottom-width:1px\">\u5206\u985e\u7d71\u8a08<\/h2>\n<div class=\"st\"><div class=\"st-bar\" style=\"width:71.42857142857143%;background:#4472C4\"><\/div><span class=\"st-lb\">\u85e5\u7269<\/span><span class=\"st-ct\">5<\/span><\/div><div class=\"st\"><div class=\"st-bar\" style=\"width:14.285714285714285%;background:#70AD47\"><\/div><span class=\"st-lb\">\u65b0\u8208\u7642\u6cd5<\/span><span class=\"st-ct\">1<\/span><\/div><div class=\"st\"><div class=\"st-bar\" style=\"width:14.285714285714285%;background:#5B9BD5\"><\/div><span class=\"st-lb\">\u6578\u4f4d\u5065\u5eb7\u91ab\u7642\u79d1\u6280<\/span><span class=\"st-ct\">1<\/span><\/div>\n<\/section>\n<!-- footer \u5df2\u79fb\u9664(v2.14.0) -->\n<\/main>\n\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>2026 \u5e74 07 \u6708 13 \u65e5 \u751f\u91ab\u5927\u5065\u5eb7\u7522\u696d\u65e5\u5831 \u5171\u6536\u9304 7 \u5247\u7522\u696d\u76f8\u95dc\u65b0\u805e \u00b7 2 \u5247\u7cbe\u9078\u6df1\u5ea6\u5206\u6790 \u7cbe\u9078 [&hellip;]<\/p>\n","protected":false},"author":5,"featured_media":0,"parent":7356,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"100-width.php","meta":{"rank_math_title":"\u751f\u91ab\u5927\u5065\u5eb7\u7522\u696d\u65e5\u5831 2026-07-13\uff5cGSK \u5728\u5169\u6b21\u81e8\u5e8a\u5931\u6557\u5f8c\uff0c\u7d42\u6b62\u8207 Alector \u7e3d","rank_math_description":"2026 \u5e74 07 \u6708 13 \u65e5 \u751f\u91ab\u5927\u5065\u5eb7\u7522\u696d\u65e5\u5831\uff1aGSK \u5728\u5169\u6b21\u81e8\u5e8a\u5931\u6557\u5f8c\uff0c\u7d42\u6b62\u8207 Alector \u7e3d\u984d 7 \u5104\u7f8e\u5143\u7684\u963f\u3001Fate Therapeutics \u7684\u73fe\u6210\u578b CAR-T \u7d30\u80de\u7642\u6cd5\u5728\u96e3\u3002\u5171\u6536\u9304 7 \u5247\u7522\u696d\u76f8\u95dc\u65b0\u805e,\u542b\u6df1\u5ea6\u5206\u6790\u3001\u53cd\u9762\u89c0\u9ede\u8207\u77ed\u4e2d\u9577\u671f\u89c0\u5bdf\u91cd\u9ede\u3002","rank_math_focus_keyword":"\u751f\u91ab\u5927\u5065\u5eb7","rank_math_robots":"","daily_schema_jsonld":"[\n  {\n    \"@context\": \"https:\/\/schema.org\",\n    \"@type\": \"CollectionPage\",\n    \"name\": \"\u751f\u91ab\u5927\u5065\u5eb7\u7522\u696d\u65e5\u5831 2026-07-13\uff5cGSK \u5728\u5169\u6b21\u81e8\u5e8a\u5931\u6557\u5f8c\uff0c\u7d42\u6b62\u8207 Alector \u7e3d\",\n    \"description\": \"2026 \u5e74 07 \u6708 13 \u65e5 \u751f\u91ab\u5927\u5065\u5eb7\u7522\u696d\u65e5\u5831\uff1aGSK \u5728\u5169\u6b21\u81e8\u5e8a\u5931\u6557\u5f8c\uff0c\u7d42\u6b62\u8207 Alector \u7e3d\u984d 7 \u5104\u7f8e\u5143\u7684\u963f\u3001Fate Therapeutics \u7684\u73fe\u6210\u578b CAR-T \u7d30\u80de\u7642\u6cd5\u5728\u96e3\u3002\u5171\u6536\u9304 7 \u5247\u7522\u696d\u76f8\u95dc\u65b0\u805e,\u542b\u6df1\u5ea6\u5206\u6790\u3001\u53cd\u9762\u89c0\u9ede\u8207\u77ed\u4e2d\u9577\u671f\u89c0\u5bdf\u91cd\u9ede\u3002\",\n    \"url\": \"https:\/\/witology.com.tw\/daily\/2026-07-13\",\n    \"datePublished\": \"2026-07-13\",\n    \"inLanguage\": \"zh-TW\",\n    \"publisher\": {\n      \"@type\": \"Organization\",\n      \"name\": \"\u667a\u749e\u79d1\u6280\",\n      \"logo\": {\n        \"@type\": \"ImageObject\",\n        \"url\": \"https:\/\/witology.com.tw\/logo.png\"\n      }\n    },\n    \"isPartOf\": {\n      \"@type\": \"WebSite\",\n      \"name\": \"\u667a\u749e\u79d1\u6280\",\n      \"url\": \"https:\/\/witology.com.tw\"\n    },\n    \"hasPart\": [\n      {\n        \"@type\": \"NewsArticle\",\n        \"headline\": \"GSK \u5728\u5169\u6b21\u81e8\u5e8a\u5931\u6557\u5f8c\uff0c\u7d42\u6b62\u8207 Alector \u7e3d\u984d 7 \u5104\u7f8e\u5143\u7684\u963f\u8332\u6d77\u9ed8\u75c7\u5408\u4f5c\u8a08\u756b\",\n        \"datePublished\": \"2026-07-13\",\n        \"dateModified\": \"2026-07-13\",\n        \"image\": [\n          \"https:\/\/witology.com.tw\/logo.png\"\n        ],\n        \"author\": {\n          \"@type\": \"Organization\",\n          \"name\": \"\u667a\u749e\u79d1\u6280\u7de8\u8f2f\u90e8\"\n        },\n        \"publisher\": {\n          \"@type\": \"Organization\",\n          \"name\": \"\u667a\u749e\u79d1\u6280\",\n          \"logo\": {\n            \"@type\": \"ImageObject\",\n            \"url\": \"https:\/\/witology.com.tw\/logo.png\"\n          }\n        },\n        \"mainEntityOfPage\": {\n          \"@type\": \"WebPage\",\n          \"@id\": \"https:\/\/witology.com.tw\/daily\/2026-07-13#article-1\"\n        },\n        \"description\": \"GSK \u5ba3\u5e03\u7d42\u6b62\u8207\u795e\u7d93\u514d\u75ab\u5b78\u65b0\u5275 Alector \u7684\u963f\u8332\u6d77\u9ed8\u75c7\u5408\u4f5c\u5354\u8b70\uff0c\u6b64\u5408\u4f5c\u65bc 2020 \u5e74\u7c3d\u8a02\u6642\u5148\u671f\u4ed8\u6b3e\u9ad8\u9054 7 \u5104\u7f8e\u5143\uff0c\u7e3d\u6f5b\u5728\u91cc\u7a0b\u7891\u91d1\u984d\u66f4\u903e 15 \u5104\u7f8e\u5143\u3002\u5169\u6b3e\u5019\u9078\u85e5\u7269\uff08AL002 \u91dd\u5c0d TREM2 \u8def\u5f91\u3001AL003 \u91dd\u5c0d CD33 \u8def\u5f91\uff09\u5728\u81e8\u5e8a\u8a66\u9a57\u4e2d\u76f8\u7e7c\u5931\u6557\uff0cGSK \u6c7a\u5b9a\u8a8d\u8ce0\u51fa\u5834\u3002\u6b64\u8209\u51f8\u986f\u4ee5\u5148\u5929\u514d\u75ab\uff0f\u795e\u7d93\u708e\u75c7\u70ba\u9776\u9ede\u7684\u963f\u8332\u6d77\u9ed8\u75c7\u7b56\u7565\u9762\u81e8\u56b4\u5cfb\u6311\u6230\uff0c\u4e5f\u53cd\u6620\u5927\u85e5\u5ee0\u5728 AD \u7ba1\u7dda\u6574\u7406\u4e0a\u6108\u8da8\u4fdd\u5b88\u3002\",\n        \"url\": \"https:\/\/witology.com.tw\/daily\/2026-07-13#article-1\",\n        \"isBasedOn\": \"https:\/\/www.fiercebiotech.com\/biotech\/gsk-cuts-losses-700m-upfront-alzheimers-collab-alector-following-two-clinical-failures\",\n        \"about\": [\n          {\n            \"@type\": \"Corporation\",\n            \"name\": \"GSK\",\n            \"tickerSymbol\": \"GSK\"\n          },\n          {\n            \"@type\": \"Corporation\",\n            \"name\": \"Alector\",\n            \"tickerSymbol\": \"ALEC\"\n          },\n          {\n            \"@type\": \"Corporation\",\n            \"name\": \"Biogen\",\n            \"tickerSymbol\": \"BIIB\"\n          },\n          {\n            \"@type\": \"Corporation\",\n            \"name\": \"Eisai\",\n            \"tickerSymbol\": \"4523\"\n          },\n          {\n            \"@type\": \"Corporation\",\n            \"name\": \"Eli Lilly\",\n            \"tickerSymbol\": \"LLY\"\n          },\n          {\n            \"@type\": \"Corporation\",\n            \"name\": \"Roche\",\n            \"tickerSymbol\": \"ROG\"\n          }\n        ]\n      },\n      {\n        \"@type\": \"NewsArticle\",\n        \"headline\": \"Fate Therapeutics \u7684\u73fe\u6210\u578b CAR-T \u7d30\u80de\u7642\u6cd5\u5728\u96e3\u6cbb\u6027\u81ea\u9ad4\u514d\u75ab\u75be\u75c5\u4e2d\u5c55\u73fe\u65e9\u671f\u7642\u6548\",\n        \"datePublished\": \"2026-07-13\",\n        \"dateModified\": \"2026-07-13\",\n        \"image\": [\n          \"https:\/\/witology.com.tw\/logo.png\"\n        ],\n        \"author\": {\n          \"@type\": \"Organization\",\n          \"name\": \"\u667a\u749e\u79d1\u6280\u7de8\u8f2f\u90e8\"\n        },\n        \"publisher\": {\n          \"@type\": \"Organization\",\n          \"name\": \"\u667a\u749e\u79d1\u6280\",\n          \"logo\": {\n            \"@type\": \"ImageObject\",\n            \"url\": \"https:\/\/witology.com.tw\/logo.png\"\n          }\n        },\n        \"mainEntityOfPage\": {\n          \"@type\": \"WebPage\",\n          \"@id\": \"https:\/\/witology.com.tw\/daily\/2026-07-13#article-2\"\n        },\n        \"description\": \"Fate Therapeutics \u516c\u5e03\u5176\u7570\u9ad4\uff08\u73fe\u6210\u578b\uff09CAR-T \u7d30\u80de\u7642\u6cd5 FT819 \u5728\u6cbb\u7642\u96e3\u6cbb\u6027\u81ea\u9ad4\u514d\u75ab\u75be\u75c5\uff08\u5982\u7cfb\u7d71\u6027\u7d05\u6591\u72fc\u7621\u3001\u91cd\u75c7\u808c\u7121\u529b\u7b49\uff09\u7684\u65e9\u671f\u81e8\u5e8a\u6578\u64da\uff0c\u986f\u793a\u51fa\u521d\u6b65\u7642\u6548\u8a0a\u865f\u4e14\u5b89\u5168\u6027\u53ef\u63a5\u53d7\u3002\u76f8\u8f03\u65bc\u81ea\u9ad4 CAR-T\uff0cFate \u7684\u7570\u9ad4\u5e73\u53f0\u4f7f\u7528\u5065\u5eb7\u6350\u8d08\u8005\u7684 iPSC \u4f86\u6e90 T \u7d30\u80de\uff0c\u53ef\u505a\u5230\u300c\u73fe\u6210\u5373\u7528\u300d\uff0c\u89e3\u6c7a\u81ea\u9ad4\u7d30\u80de\u88fd\u9020\u6642\u9593\u904e\u9577\u7684\u75db\u9ede\u3002\u9019\u662f CAR-T \u7642\u6cd5\u5f9e\u8840\u6db2\u816b\u7624\u8de8\u5165\u81ea\u9ad4\u514d\u75ab\u75be\u75c5\u7684\u91cd\u8981\u81e8\u5e8a\u9032\u5c55\",\n        \"url\": \"https:\/\/witology.com.tw\/daily\/2026-07-13#article-2\",\n        \"isBasedOn\": \"https:\/\/www.fiercebiotech.com\/biotech\/fates-shelf-car-t-cell-therapy-shows-early-promise-treatment-resistant-autoimmune-disease\",\n        \"about\": [\n          {\n            \"@type\": \"Corporation\",\n            \"name\": \"Fate Therapeutics\",\n            \"tickerSymbol\": \"FATE\"\n          },\n          {\n            \"@type\": \"Corporation\",\n            \"name\": \"Bristol Myers Squibb\",\n            \"tickerSymbol\": \"BMY\"\n          },\n          {\n            \"@type\": \"Corporation\",\n            \"name\": \"Kyverna Therapeutics\",\n            \"tickerSymbol\": \"KYTX\"\n          },\n          {\n            \"@type\": \"Corporation\",\n            \"name\": \"Cartesian Therapeutics\",\n            \"tickerSymbol\": \"CRXT\"\n          },\n          {\n            \"@type\": \"Corporation\",\n            \"name\": \"Novartis\",\n            \"tickerSymbol\": \"NVS\"\n          },\n          {\n            \"@type\": \"Corporation\",\n            \"name\": \"Johnson & Johnson\",\n            \"tickerSymbol\": \"JNJ\"\n          },\n          {\n            \"@type\": \"Corporation\",\n            \"name\": \"\u9577\u8056\u570b\u969b\u751f\u6280\",\n            \"tickerSymbol\": \"6712\"\n          }\n        ]\n      }\n    ]\n  },\n  {\n    \"@context\": \"https:\/\/schema.org\",\n    \"@type\": \"BreadcrumbList\",\n    \"itemListElement\": [\n      {\n        \"@type\": \"ListItem\",\n        \"position\": 1,\n        \"name\": \"\u9996\u9801\",\n        \"item\": \"https:\/\/witology.com.tw\"\n      },\n      {\n        \"@type\": \"ListItem\",\n        \"position\": 2,\n        \"name\": \"\u751f\u91ab\u5927\u5065\u5eb7\u7522\u696d\u65e5\u5831\",\n        \"item\": \"https:\/\/witology.com.tw\/daily\"\n      },\n      {\n        \"@type\": \"ListItem\",\n        \"position\": 3,\n        \"name\": \"2026-07-13\",\n        \"item\": \"https:\/\/witology.com.tw\/daily\/2026-07-13\"\n      }\n    ]\n  },\n  {\n    \"@context\": \"https:\/\/schema.org\",\n    \"@type\": \"FAQPage\",\n    \"mainEntity\": [\n      {\n        \"@type\": \"Question\",\n        \"name\": \"GSK \u6295\u5165\u7684 7 \u5104\u7f8e\u5143\u5c31\u9019\u6a23\u6253\u6c34\u6f02\u4e86\u55ce\uff1f\",\n        \"acceptedAnswer\": {\n          \"@type\": \"Answer\",\n          \"text\": \"\u57fa\u672c\u4e0a\u662f\u7684\u3002\u5148\u671f\u4ed8\u6b3e\u5c6c\u65bc\u4e0d\u53ef\u9000\u6b3e\u6027\u8cea\uff0c\u5169\u6b3e\u5019\u9078\u85e5\u7269\u81e8\u5e8a\u5931\u6557\u5f8c GSK \u7121\u6cd5\u56de\u6536\u9019\u7b46\u6b3e\u9805\uff1b\u4f46\u7d42\u6b62\u5408\u4f5c\u53ef\u907f\u514d\u672a\u4f86\u7e7c\u7e8c\u71d2\u9322\u5728\u7121\u6548\u7ba1\u7dda\u4e0a\uff0c\u5c0d GSK \u800c\u8a00\u662f\u300c\u6b62\u8840\u300d\u800c\u975e\u300c\u7372\u5229\u300d\u7684\u6c7a\u7b56\u3002\"\n        }\n      },\n      {\n        \"@type\": \"Question\",\n        \"name\": \"\u9019\u6b21\u5931\u6557\u4ee3\u8868\u963f\u8332\u6d77\u9ed8\u75c7\u7684\u795e\u7d93\u708e\u75c7\u7642\u6cd5\u6574\u689d\u8def\u90fd\u8d70\u4e0d\u901a\u55ce\uff1f\",\n        \"acceptedAnswer\": {\n          \"@type\": \"Answer\",\n          \"text\": \"\u76ee\u524d\u4e0d\u80fd\u5b8c\u5168\u4e0b\u9019\u500b\u7d50\u8ad6\uff0c\u4f46 TREM2 \u8207 CD33 \u5169\u500b\u9776\u9ede\u76f8\u7e7c\u5728\u81e8\u5e8a\u5931\u6557\uff0c\u78ba\u5be6\u8b93\u5e02\u5834\u5c0d\u5148\u5929\u514d\u75ab\u8def\u5f91\u7684\u4fe1\u5fc3\u5927\u5e45\u4e0b\u6ed1\uff1b\u76ee\u524d\u79d1\u5b78\u754c\u5171\u8b58\u4ecd\u504f\u5411\u6297\u6fb1\u7c89\u86cb\u767d\u8def\u5f91\uff08\u5982 lecanemab\uff09\u662f\u6700\u63a5\u8fd1\u81e8\u5e8a\u6709\u6548\u7684\u7b56\u7565\uff0c\u795e\u7d93\u708e\u75c7\u8def\u5f91\u9700\u8981\u66f4\u7cbe\u6e96\u7684\u60a3\u8005\u7be9\u9078\u8207\u751f\u7269\u6a19\u8a18\u624d\u53ef\u80fd\u7ffb\u76e4\u3002\"\n        }\n      },\n      {\n        \"@type\": \"Question\",\n        \"name\": \"Alector \u63a5\u4e0b\u4f86\u600e\u9ebc\u8fa6\uff0c\u9019\u5bb6\u516c\u53f8\u9084\u6709\u6551\u55ce\uff1f\",\n        \"acceptedAnswer\": {\n          \"@type\": \"Answer\",\n          \"text\": \"Alector \u76ee\u524d\u4ecd\u6709\u5176\u4ed6\u7ba1\u7dda\uff08\u5982\u91dd\u5c0d FTD \u7684 progranulin \u8def\u5f91 AL101\uff09\uff0c\u4f46\u5931\u53bb GSK \u7684\u8cc7\u91d1\u652f\u6301\u5f8c\u73fe\u91d1\u8dd1\u9053\u58d3\u529b\u5927\u589e\uff0c\u77ed\u671f\u5167\u9700\u8981\u5c0b\u627e\u65b0\u7684\u6388\u6b0a\u5925\u4f34\u6216\u9032\u884c\u878d\u8cc7\uff0c\u80a1\u50f9\u8207\u516c\u53f8\u5b58\u7e8c\u98a8\u96aa\u5747\u986f\u8457\u4e0a\u5347\u3002\"\n        }\n      },\n      {\n        \"@type\": \"Question\",\n        \"name\": \"\u300c\u73fe\u6210\u578b\u300dCAR-T \u548c\u4e00\u822c CAR-T \u6709\u4ec0\u9ebc\u4e0d\u540c\uff0c\u70ba\u4ec0\u9ebc\u9019\u5f88\u91cd\u8981\uff1f\",\n        \"acceptedAnswer\": {\n          \"@type\": \"Answer\",\n          \"text\": \"\u4e00\u822c\uff08\u81ea\u9ad4\uff09CAR-T \u9700\u8981\u62bd\u53d6\u75c5\u4eba\u81ea\u5df1\u7684 T \u7d30\u80de\u3001\u6539\u9020\u5f8c\u518d\u56de\u8f38\uff0c\u6574\u500b\u904e\u7a0b\u9700 4\u20136 \u9031\u4e14\u8cbb\u7528\u6975\u9ad8\uff1b\u300c\u73fe\u6210\u578b\u300d\uff08\u7570\u9ad4\uff09CAR-T \u4f7f\u7528\u5065\u5eb7\u6350\u8d08\u8005\u7d30\u80de\u9810\u5148\u5927\u91cf\u88fd\u9020\uff0c\u75c5\u4eba\u9700\u8981\u6642\u53ef\u7acb\u5373\u4f7f\u7528\uff0c\u7406\u8ad6\u4e0a\u6210\u672c\u66f4\u4f4e\u3001\u7b49\u5f85\u6642\u9593\u66f4\u77ed\uff0c\u5c0d\u91cd\u75c7\u60a3\u8005\u5c24\u5176\u95dc\u9375\u3002\"\n        }\n      },\n      {\n        \"@type\": \"Question\",\n        \"name\": \"CAR-T \u7642\u6cd5\u7528\u65bc\u81ea\u9ad4\u514d\u75ab\u75be\u75c5\u548c\u7528\u65bc\u764c\u75c7\u6cbb\u7642\u6709\u4f55\u4e0d\u540c\uff1f\",\n        \"acceptedAnswer\": {\n          \"@type\": \"Answer\",\n          \"text\": \"\u5728\u764c\u75c7\u4e2d\uff0cCAR-T \u7684\u76ee\u6a19\u662f\u6d88\u6ec5\u816b\u7624\u7d30\u80de\uff1b\u5728\u81ea\u9ad4\u514d\u75ab\u75be\u75c5\u4e2d\uff0c\u76ee\u6a19\u662f\u6e05\u9664\u300c\u932f\u8aa4\u653b\u64ca\u81ea\u8eab\u7d44\u7e54\u300d\u7684\u7570\u5e38 B \u7d30\u80de\uff0c\u8b93\u514d\u75ab\u7cfb\u7d71\u91cd\u65b0\u5efa\u7acb\u6b63\u78ba\u7684\u8010\u53d7\u6a5f\u5236\uff0c\u56e0\u6b64\u6cbb\u7642\u908f\u8f2f\u662f\u300c\u514d\u75ab\u91cd\u7f6e\u300d\u800c\u975e\u300c\u6bba\u764c\u300d\uff0c\u5c0d\u7d30\u80de\u6bd2\u6027\u7684\u8981\u6c42\u4e5f\u4e0d\u540c\u3002\"\n        }\n      },\n      {\n        \"@type\": \"Question\",\n        \"name\": \"\u9019\u500b\u7642\u6cd5\u8ddd\u96e2\u771f\u6b63\u4e0a\u5e02\u9084\u6709\u591a\u9060\uff1f\",\n        \"acceptedAnswer\": {\n          \"@type\": \"Answer\",\n          \"text\": \"\u76ee\u524d\u50c5\u70ba\u65e9\u671f\u81e8\u5e8a\uff08Phase I\uff09\u7684\u521d\u6b65\u8a0a\u865f\uff0c\u8ddd\u96e2\u53d6\u5f97 FDA \u6279\u51c6\u901a\u5e38\u9084\u9700\u8981 5\u20138 \u5e74\u7684 Phase II\uff0fIII \u8a66\u9a57\uff1b\u52a0\u4e0a\u7570\u9ad4 CAR-T \u5728\u81ea\u9ad4\u514d\u75ab\u75be\u75c5\u7684\u76e3\u7ba1\u8def\u5f91\u5c1a\u672a\u5b8c\u5168\u78ba\u7acb\uff0c\u5546\u696d\u5316\u6642\u7a0b\u5b58\u5728\u76f8\u7576\u4e0d\u78ba\u5b9a\u6027\u3002\"\n        }\n      }\n    ]\n  }\n]","daily_standalone_url":"","footnotes":""},"class_list":["post-8257","page","type-page","status-publish","hentry"],"_links":{"self":[{"href":"https:\/\/witology.com.tw\/en\/wp-json\/wp\/v2\/pages\/8257","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/witology.com.tw\/en\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/witology.com.tw\/en\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/witology.com.tw\/en\/wp-json\/wp\/v2\/users\/5"}],"replies":[{"embeddable":true,"href":"https:\/\/witology.com.tw\/en\/wp-json\/wp\/v2\/comments?post=8257"}],"version-history":[{"count":0,"href":"https:\/\/witology.com.tw\/en\/wp-json\/wp\/v2\/pages\/8257\/revisions"}],"up":[{"embeddable":true,"href":"https:\/\/witology.com.tw\/en\/wp-json\/wp\/v2\/pages\/7356"}],"wp:attachment":[{"href":"https:\/\/witology.com.tw\/en\/wp-json\/wp\/v2\/media?parent=8257"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}